Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Enhanced immunogenicity of a Clostridioides difficile TcdB vaccine adjuvanted with a synthetic dual-TLR ligand adjuvant

npj Vaccines(2025)10.1038/s41541-025-01075-3Source: DataRank Database

Enhanced immunogenicity of a Clostridioides difficile TcdB vaccine adjuvanted with a synthetic dual-TLR ligand adjuvant is a research paper published in npj Vaccines (2025). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 3.68)OA: goldTopics (23)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Nicholas Hagspiel,Feifan Xu,Brandon Thompson ORCID,G. Brett Moreau ORCID,Mary Young ORCID

Live enrichment

PubMed:39966390 PMC:PMC11836405 OpenAlex:https://openalex.org/W4407695926

National Institutes of Health

Grant: R01 AI152477 and R01 AI124214

NIAID NIH HHS

Grant: T32 AI007392

NIAID NIH HHS

Grant: R01 AI124214

NIAID NIH HHS

Grant: R01 AI152477

National Institutes of Health

Grant: 5R01AI152477-05

Role of Th17 in Severe and Recurrent C. difficile Infection

National Institutes of Health

Grant: 2R01AI124214-06

Role of Type 2 Immunity in Innate Protection from C. difficile

FWCI

3.68

Citation Percentile

0.9%

Citation Trend

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://www.nature.com/articles/s41541-025-01075-3.pdf

publisherhttps://www.nature.com/articles/s41541-025-01075-3.pdf

publisherhttps://www.nature.com/articles/s41541-025-01075-3

journalhttps://doi.org/10.1038/s41541-025-01075-3

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39966390

Fields of Study

Clostridium difficile and Clostridium perfringens researchMicroscopic ColitisViral gastroenteritis research and epidemiology0301 basic medicine03 medical and health sciences

Keywords

AdjuvantImmunogenicityClostridioidesMedicineVaccine adjuvantVirologyPharmacologyMicrobiologyImmunologyBiologyImmune systemInternal medicineNeoplasms. Tumors. Oncology. Including cancer and carcinogensImmunologic diseases. AllergyRC581-607Brief CommunicationRC254-282Article

Sustainable Development Goals

SDG 0: Zero hunger

Enhanced immunogenicity of a Clostridioides difficile TcdB vaccine adjuvanted with a synthetic dual-TLR ligand adjuvant

FAIR Checklist

Authors (10)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)